The peptide has been investigated for its interactions with tight junction protein expression, mucosal blood flow regulation, and enteric nervous system signaling when delivered orally
Research Support and Efficacy Numerous clinical trials have demonstrated the effectiveness of semaglutide for weight loss: Clinical Trials : In a pivotal study involving approximately 2,000 adults with obesity or overweight (without diabetes), those using semaglutide in conjunction with lifestyle modifications lost an average of 14.9% of their body weight over 68 weeks, compared to a mere 2.4% weight loss in the placebo group
A 2022 study in Diabetes, Obesity and Metabolism showed that NNMTi treatment combined with reduced-calorie diet "promoted dramatic whole-body adiposity and weight loss in diet-induced obese mice, rapidly normalizing" weight parameters
Researchers initially identified BPC-157 while analyzing human gastric secretions
Cycle Length: 4 weeks on, then 24 weeks off before any repeat cycle